🇺🇸 FDA

Company profile · Sponsor

Iterum

Iterum Therapeutics plc

ITRMF · NYSE pharma DUBLIN 1, L2, USA
Pipeline
8
Drugs
0
Patents
3

Quick answer

Iterum (ITRMF) is a pharma company. headquartered in DUBLIN 1, L2, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 3 patents to this profile..

Company facts

Ticker ITRMF
Exchange NYSE
Company type pharma
Headquarters DUBLIN 1, L2, USA
SEC CIK 0001659323

Pipeline (8)

Search pipeline →

  1. Azithromycin plus hydroxychloroquine

    Iterum

    Respiratory Tract Infection Viral

    phase 3 small molecule terminated

    1 trial

  2. Ertapenem

    Iterum

    Intra Abdominal Infections

    phase 3 small molecule completed

    1 trial

  3. Sulopenem

    Iterum

    Complicated Urinary Tract Infections

    phase 3 small molecule completed

    1 trial

  4. Sulopenem etzadroxil/probenecid

    Iterum

    Urinary Tract Infections

    phase 3 small molecule completed

    1 trial

  5. Sulopenem-Etzadroxil/Probenecid

    Iterum

    Uncomplicated Urinary Tract Infections

    phase 3 small molecule completed

    1 trial

  6. Sulopenem

    Iterum

    Urinary Tract Infections

    phase 1 small molecule terminated

    1 trial

  7. sulopenem etzadroxil and probenecid

    Iterum

    Pharmacokinetics After Oral Intake

    phase 1 small molecule active

    1 trial

  8. Ciprofloxacin

    Iterum

    UTI - Lower Urinary Tract Infection

    approved small molecule completed

    1 trial

Patents (3)

Search patents →

  1. US 12128034

    Combinations of beta-lactam compounds, probenecid, and valproic acid and uses thereof

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12109197

    Combinations of β-lactam compounds and probenecid and uses thereof

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11478428

    Combinations of beta-lactam compounds and probenecid and uses thereof

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Iterum?

Iterum (ITRMF) is a pharma company. headquartered in DUBLIN 1, L2, USA. listed on NYSE. NovaPharmaNews links 8 pipeline programs, 0 drugs, and 3 patents to this profile..

What pipeline programs does Iterum sponsor?

We track 8 ClinicalTrials.gov-linked programs for Iterum, including Azithromycin plus hydroxychloroquine and 7 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Iterum company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.